Astera Labs, Inc. (ALAB) stock declined 5.19% in post-market trading, following a significant intraday surge.
The after-hours drop is attributed to investors locking in profits after the stock's sharp 9.2% gain during the regular session. UBS initiated coverage with a Neutral rating and a $180 price target, which is below the stock's current trading level, contributing to the negative sentiment. Additionally, SEC filings revealed proposed sales of securities by insiders, further weighing on investor confidence.
Earlier in the day, the stock had rallied on optimism surrounding AI infrastructure spending after Amazon announced a landmark $100 billion deal with Anthropic, with analysts highlighting Astera Labs as a key beneficiary.
Comments